Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Kushen Pian is a traditional Chinese medicine (TCM) tablet manufactured by Liaoning Jindan Pharmaceutical, derived from the root of *Sophora flavescens*. It is an approved pharmaceutical product in China, primarily used for its heat-clearing, dampness-drying, and insecticidal properties. The active components are quinolizidine alkaloids, specifically matrine and oxymatrine, which provide anti-inflammatory, antibacterial, and anti-itch effects. Clinical indications typically include damp-heat induced diarrhea, jaundice, leukorrhea with reddish discharge, and skin ailments such as eczema and pruritus.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on kushen pian.